Researchers have developed a highly sensitive single-molecule sequencing technique that could be used to study somatic mutations in a wide range of normal tissues, including those that aren't actively dividing. The technique, called NanoSeq, has several potential cancer applications, including studying mutagenesis and exploring somatic mutations that occur prior to cancer.

You do not currently have access to this content.